refractory CTCL

Related by string. * Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . hormone refractory prostate cancer . relapsed refractory AML . refractory anemia . rituximab refractory follicular . refractory multiple myeloma . refractory rituximab naive . refractory APL / Ct. Cl : cell lymphoma CTCL . Cell Lymphoma CTCL . CTCL . lymphoma CTCL * *

Related by context. Frequent words. (Click for all words.) 68 refractory multiple myeloma 67 metastatic renal cell carcinoma 66 axitinib 66 refractory Hodgkin lymphoma 65 relapsed refractory 64 relapsed multiple myeloma 64 B CLL 63 FOLFIRI 63 PXD# 63 advanced NSCLC 63 Taxotere R 63 nab paclitaxel 63 TORISEL 63 cutaneous T cell 63 refractory PTCL 62 IV melanoma 62 opioid induced constipation 62 castration resistant prostate cancer 62 HGS ETR1 62 chronic lymphocytic leukemia CLL 62 Taxotere ® 62 vinorelbine 62 relapsing remitting multiple sclerosis 62 TYKERB 62 temsirolimus 62 HRPC 61 relapsed 61 plus gemcitabine 61 NSCLC 61 refractory peripheral T 61 vandetanib 61 resistant ovarian cancer 61 decitabine 61 BAY #-# 61 anti thrombotic 61 nilotinib 61 hepatocellular carcinoma HCC 61 Torisel 61 dacarbazine 61 FOLOTYN 61 eltrombopag 61 androgen independent 61 dose cohorts 61 AP# [003] 60 DMARD 60 unresectable 60 temozolomide 60 medullary thyroid cancer 60 COPAXONE R 60 acute myelogenous leukemia AML 60 OXi# 60 mCRC 60 monotherapy 60 tocilizumab 60 CA4P 60 metastatic colorectal cancer 60 RG# [001] 60 PegIntron 60 sorafenib 60 xenograft models 60 mitoxantrone 60 adalimumab 60 SUTENT 60 Jevtana 60 systemic lupus erythematosus 60 hematological malignancies 60 chronic myeloid leukemia CML 59 anticancer therapy 59 romidepsin 59 Bortezomib 59 epirubicin 59 eculizumab 59 Bevacizumab 59 Acute Myeloid Leukemia AML 59 azacitidine 59 brain metastases 59 imetelstat 59 pemetrexed 59 dasatinib 59 diabetic neuropathic pain 59 glioblastoma multiforme GBM 59 biologic therapy 59 IMC A# 59 IMGN# 59 cytogenetic response 59 MGCD# [001] 59 pralatrexate 59 hematologic malignancies 59 anti TNF alpha 59 PROMACTA 58 etoposide 58 topotecan 58 erlotinib 58 TELCYTA 58 chronic angina 58 TNF blocking 58 interferon alfa 58 recurrent ovarian cancer 58 plus prednisone 58 solid tumors 58 CYC#

Back to home page